Acquisition of Filovirus Point-of-Care (PoC) Diagnostic Tests
Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
- Original Published Date: May 19, 2022 03:06 pm EDT
- Original Date Offers Due: May 23, 2022 03:00 pm EDT
- Inactive Policy: 15 days after date offers due
- Original Inactive Date: Jun 07, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code:
- NAICS Code:
- Place of Performance: Bethlehem , PA 18015USA
Description
The Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS) seeks to purchase diagnostic tests for Ebola virus. The test must be a point of care, handheld, lateral flow, rapid antigen test for Ebola virus that is either emergency use authorized or 510(k) cleared by the U.S. Food and Drug Administration. The test sample type must be oral fluid from cadavers. The test must be for use on individuals suspected to have recently died from the Ebola virus disease.
OraSure Technologies is uniquely qualified because their product is the only test that meets all the following salient characteristics:
- For point of care use
- Handheld
- Lateral flow, rapid antigen test for Ebola virus
- Either emergency use authorized, or Section 510(k) cleared by the U.S. Food and Drug Administration (FDA)
- Samples oral fluid from cadavers
- For use on individuals or suspected to have recently died from the Ebola virus disease
- Nine (9) month shelf life from date of delivery
Alternative tests will not work because the Government will be unable to assess infection with the Ebola Virus in individuals and cadavers. The inability to assess infections would jeopardize HHS’ public health mission in a way that would result in unacceptable risks to the health of the public.
Attachments/Links
Contact Information
Primary Point of Contact
- Amber Gray
- amber.gray@hhs.gov
Secondary Point of Contact
- Davis Perkins
- davis.perkins@hhs.gov